Matrix metalloproteinase inhibitors in rheumatic diseases (Q34560579)

3 August 2017

1 reference

title

Matrix metalloproteinase inhibitors in rheumatic diseases (English)

1 reference

3 August 2017

Close DR

1

1 reference

PubMed ID

11890658

3 August 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

Annals of the Rheumatic Diseases

3 August 2017

1 reference

3 August 2017

60 Suppl 3

1 reference

3 August 2017

iii62-7

1 reference

Tolerability and pharmacokinetics of the collagenase-selective inhibitor Trocade in patients with rheumatoid arthritis

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Serum markers of articular cartilage damage and repair

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Ro 32-3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

DC-ART: preventing or significantly decreasing the rate of progression of structural joint damage

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Total knee arthroplasty: a population-based study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Matrix metalloproteinases and their inhibitors in connective tissue remodeling

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Matrix metalloproteinase inhibitors in arthritis.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

Combined analysis of studies of the effects of the matrix metalloproteinase inhibitor marimastat on serum tumor markers in advanced cancer: selection of a biologically active and tolerable dose for longer-term studies.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1766680

The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis

27 October 2018

1 reference

12 December 2020

Monitoring radiographic changes in early rheumatoid arthritis

1 reference

12 December 2020

Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction

1 reference

12 December 2020

Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis

1 reference

12 December 2020

Serum matrix metalloproteinase 3 in early rheumatoid arthritis is correlated with disease activity and radiological progression

1 reference

12 December 2020

The impact of chronic disease: a sociomedical profile of rheumatoid arthritis

1 reference

12 December 2020

Joint destruction in arthritis: metalloproteinases in the spotlight

1 reference

12 December 2020

Radiographic progression in rheumatoid arthritis: results of 3 comparative trials

1 reference

12 December 2020

Identifiers

PMCID

1766680

1 reference

3 August 2017

1 reference

PubMed ID

11890658